Pages that link to "Q42909519"

The following pages link to Persistent occult hepatitis B virus infection: experimental findings and clinical implications (Q42909519):

Displaying 36 items.

• Genetic variation of occult hepatitis B virus infection (Q26751031) (← links)
• Occult hepatitis B virus infection (Q27004224) (← links)
• Primary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocarcinoma in the woodchuck model of hepatitis B (Q28542638) (← links)
• Occult infection with hepatitis C virus: friend or foe? (Q30416187) (← links)
• Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients (Q30431051) (← links)
• Occult hepatitis B virus and hepatocellular carcinoma (Q33661018) (← links)
• Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. (Q34080966) (← links)
• Occult hepatitis B virus and hepatitis C virus infections (Q34748898) (← links)
• Diagnostic strategy for occult hepatitis B virus infection (Q34757381) (← links)
• Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study (Q36190007) (← links)
• Occult HBV infection (Q36518847) (← links)
• Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis (Q36559497) (← links)
• Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor (Q36623471) (← links)
• Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation (Q36876536) (← links)
• Hepatitis B viruses: reverse transcription a different way. (Q37109700) (← links)
• Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infection (Q37145259) (← links)
• Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA. (Q37232154) (← links)
• Molecular characteristics and stages of chronic hepatitis B virus infection (Q37250341) (← links)
• Occult Hepatitis B: Clinical Implications and Treatment Decisions (Q37798473) (← links)
• Pathogenesis of occult chronic hepatitis B virus infection (Q37862591) (← links)
• Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis (Q38125450) (← links)
• Designing primers from multiple sequences using Matchup program to improve detection of hepatitis B virus by polymerase chain reaction (Q38345854) (← links)
• Molecular mechanisms underlying HBsAg negativity in occult HBV infection (Q38536404) (← links)
• Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients (Q38989985) (← links)
• Occult hepatitis B virus infection: clinical implications in tuberculosis treatment (Q39394078) (← links)
• Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection. (Q39764120) (← links)
• Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells (Q39903499) (← links)
• Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B (Q42004056) (← links)
• Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial (Q42242620) (← links)
• The clinical significance of occult HBV infection (Q42406515) (← links)
• The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis (Q42939279) (← links)
• Occult hepatitis B: clinical viewpoint and management. (Q43223881) (← links)
• The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies (Q45356038) (← links)
• Occult hepatitis B virus infection in Thai blood donors (Q45369715) (← links)
• Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin (Q50560155) (← links)
• A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection (Q56979536) (← links)